Versatile Biotinylated Sars-cov-2 Spike S1 Protein (cov-vm5s1b) Bundle [bX1iT7aO]

Biotinylated SARS-CoV-2 Spike S1 Protein (COV-VM5S1B)

Introducing the Biotinylated SARS-CoV-2 Spike S1 Protein (COV-VM5S1B), a cutting-edge research tool designed for high-precision studies on the novel coronavirus. This protein is meticulously engineered to mimic the structure of the SARS-CoV-2 spike protein, enabling researchers to delve deeper into the virus's behavior and develop effective countermeasures. With its exceptional purity and stability, the COV-VM5S1B is the ideal choice for a wide range of applications in virology, immunology, and vaccine development.

Key Features and Specifications

The Biotinylated SARS-CoV-2 Spike S1 Protein (COV-VM5S1B) boasts several key features that make it a standout product in the market. First and foremost, it is produced using state-of-the-art biotechnology, ensuring a high level of purity and consistency. Additionally, the protein is biotinylated, which enhances its binding affinity and allows for easier detection and manipulation in various experimental settings. Here are some of the key specifications:

• Purity: >95%
• Concentration: 1mg/mL
• Storage: -20°C

These features make the COV-VM5S1B an invaluable asset for researchers seeking to advance our understanding of SARS-CoV-2 and develop innovative solutions.

Practical Applications and Benefits

The Biotinylated SARS-CoV-2 Spike S1 Protein (COV-VM5S1B) offers a multitude of practical applications in the field of virology. Its biotinylated nature allows for convenient conjugation with various detection and labeling agents, making it ideal for use in ELISA, Western blot, and immunofluorescence assays. Moreover, the protein's structural similarity to the actual spike protein enables researchers to study the virus's interaction with antibodies and other immune components. Here are some of the key benefits:

• Enhanced Research Efficiency: Facilitates the development of diagnostic tests and therapeutic agents.
• Improved Data Accuracy: Enables more reliable and reproducible experimental results.

With the Biotinylated SARS-CoV-2 Spike S1 Protein (COV-VM5S1B), researchers can make significant strides in the fight against COVID-19 and other coronaviruses.